Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Mersana Therapeutics buy BTIG Research

Start price
€0.26
13.08.25 / 50%
Target price
-
13.08.26
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 13.08.26. The prediction end date can be changed by BTIG_Research at any time.
Performance without dividends (%)
Name 1w
Mersana Therapeutics -
iShares Core DAX® 1.043%
iShares Nasdaq 100 1.920%
iShares Nikkei 225® 4.840%
iShares S&P 500 1.567%

Comments by BTIG_Research for this prediction

In the thread Mersana Therapeutics diskutieren

Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its "buy" rating re-affirmed by analysts at BTIG Research.
Ratings data for MRSN provided by MarketBeat

Stopped prediction by BTIG_Research for Mersana Therapeutics

buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€5.00
29.02.24
€5.54
28.02.25
-90.28%
01.03.25